{"id":47738,"date":"2022-08-29T12:01:58","date_gmt":"2022-08-29T10:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/"},"modified":"2022-08-29T12:01:58","modified_gmt":"2022-08-29T10:01:58","slug":"evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/","title":{"rendered":"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference"},"content":{"rendered":"
\n

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–$EOLS<\/a>–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the H.C. Wainwright 24th<\/sup> Annual Global Investment Conference.\n<\/p>\n

<\/a><\/p>\n\n\n\n\n
\n

\nEvent:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\nH.C. Wainwright 24th<\/sup> Annual Global Investment Conference\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\nMonday, September 12, 2022\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:<\/b>\n<\/p>\n<\/td>\n

<\/td>\n\n

\nAvailable on-demand starting at 7:00 am ET\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nAn audio webcast of this event will be available on the investor relations section of Evolus\u2019 website at www.evolus.com<\/a>. A replay of the webcast will be available for 90 days after the date of the presentation.\n<\/p>\n

\nAbout Evolus, Inc.<\/b>\n<\/p>\n

\nEvolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau\u00ae<\/sup> (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure\u2122 technology. Visit us at www.evolus.com<\/a>, and follow us on LinkedIn<\/a>, Twitter<\/a>, Instagram<\/a> or Facebook<\/a>.\n<\/p>\n

\nJeuveau\u00ae<\/sup> is a registered trademark of Evolus, Inc.\n<\/p>\n

\nHi-Pure\u2122<\/sup> is a trademark of Daewoong Pharmaceutical Co, Ltd.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor\/Media Contact:<\/span>
David K. Erickson, Evolus, Inc.
\n
Vice President, Investor Relations
\n
Tel: 949-966-1798
\n
Email: david.erickson@evolus.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–$EOLS–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference. Event: H.C. Wainwright 24th Annual Global Investment Conference Date: Monday, September 12, 2022 Time: Available … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47738","6":"format-standard","7":"category-industry"},"yoast_head":"\nEvolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEWPORT BEACH, Calif.–(BUSINESS WIRE)–$EOLS–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference. Event: H.C. Wainwright 24th Annual Global Investment Conference Date: Monday, September 12, 2022 Time: Available ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T10:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220829005046\/en\/1347984\/21\/LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference\",\"datePublished\":\"2022-08-29T10:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/\"},\"wordCount\":235,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005046\\\/en\\\/1347984\\\/21\\\/LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/\",\"name\":\"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005046\\\/en\\\/1347984\\\/21\\\/LOGO.jpg\",\"datePublished\":\"2022-08-29T10:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005046\\\/en\\\/1347984\\\/21\\\/LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005046\\\/en\\\/1347984\\\/21\\\/LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Pharma Trend","og_description":"NEWPORT BEACH, Calif.–(BUSINESS WIRE)–$EOLS–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference. Event: H.C. Wainwright 24th Annual Global Investment Conference Date: Monday, September 12, 2022 Time: Available ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-29T10:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220829005046\/en\/1347984\/21\/LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference","datePublished":"2022-08-29T10:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/"},"wordCount":235,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005046\/en\/1347984\/21\/LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/","url":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/","name":"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005046\/en\/1347984\/21\/LOGO.jpg","datePublished":"2022-08-29T10:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220829005046\/en\/1347984\/21\/LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220829005046\/en\/1347984\/21\/LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/evolus-to-participate-in-the-h-c-wainwright-24th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47738"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47738\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}